Deletion of a Stem Cell Factor Promotes TBI Recovery in Mice
UT Southwestern molecular biologists today report the unexpected finding that selectively deleting a stem cell transcription factor in adult mice promotes recovery after traumatic brain injury (TBI).
The Centers for Disease Control and Prevention defines TBI as a bump, blow, or jolt to the head that disrupts normal brain function, ranging from mild – brief changes in mental status – to severe, marked by an extended period of unconsciousness or memory loss. In humans, most TBIs are mild and are called concussions.
“Our results reveal that SOX2-dependent signaling pathways in reactive astrocytes are targets for brain recovery after traumatic injury,” said Dr. Chun-Li Zhang, Associate Professor of Molecular Biology and in the Hamon Center for Regenerative Science and Medicine. Dr. Zhang is co-corresponding author of the study.
Click here to read more.
2019 AANS/CNS Section on Pediatric Neurological Surgery Annual Meeting
Dec. 5-8, 2019; Scottsdale, Ariz.
Dec. 5-8, 2019; Mumbai, India
Miami Brain Symposium, Third Annual
Dec. 6, 2019; Miami
Surgical Spine Care: Removing Barriers to Patient Access, an ISASS Symposium
Dec. 6-7, 2019; New York
Georgia Neurosurgical Society Annual Fall Scientific Symposium
Dec. 6-7, 2019; Greensboro, Ga.